Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
0(0%)
Results Posted
54%(7 trials)

Phase Distribution

Ph phase_1
3
23%
Ph not_applicable
2
15%
Ph phase_4
2
15%
Ph phase_3
2
15%
Ph phase_2
4
31%

Phase Distribution

3

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
3(23.1%)
Phase 2Efficacy & side effects
4(30.8%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(13)

Detailed Status

Completed13

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (23.1%)
Phase 24 (30.8%)
Phase 32 (15.4%)
Phase 42 (15.4%)
N/A2 (15.4%)

Trials by Status

completed13100%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT04546633Phase 2

Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria

Completed
NCT04675931Phase 2

To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria

Completed
NCT05842954Phase 3

Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria

Completed
NCT02942277Phase 1

Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali

Completed
NCT03952650Phase 1

Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa...

Completed
NCT03167242Phase 2

Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

Completed
NCT03334747Phase 2

Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.

Completed
NCT02627456Phase 1

Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali

Completed
NCT02528279Not Applicable

Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria

Completed
NCT00119145Phase 4

Kintampo Trial of Combination Therapy for Malaria

Completed
NCT00513500Not Applicable

Zambia Integrated Management of Malaria and Pneumonia Study

Completed
NCT00699920Phase 4

Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks

Completed
NCT00484900Phase 3

Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13